Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000733592 | SCV000861674 | likely benign | not specified | 2018-06-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000969032 | SCV001116523 | benign | not provided | 2024-10-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000969032 | SCV001867574 | benign | not provided | 2019-06-26 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000969032 | SCV005224698 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Ambry Genetics | RCV004972928 | SCV005594231 | likely benign | Inborn genetic diseases | 2024-09-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |